H. Blau

782 total citations
19 papers, 591 citations indexed

About

H. Blau is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, H. Blau has authored 19 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 4 papers in Epidemiology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in H. Blau's work include Cystic Fibrosis Research Advances (11 papers), Neonatal Respiratory Health Research (9 papers) and Inhalation and Respiratory Drug Delivery (3 papers). H. Blau is often cited by papers focused on Cystic Fibrosis Research Advances (11 papers), Neonatal Respiratory Health Research (9 papers) and Inhalation and Respiratory Drug Delivery (3 papers). H. Blau collaborates with scholars based in Israel, United States and Germany. H. Blau's co-authors include Joseph Rivlin, Eitan Kerem, Huda Mussaffi, Micha Aviram, Itamar Shalit, Lea Bentur, Moshe Ephros, Liat Lerner‐Geva, A. Lavy and Galia Rahav and has published in prestigious journals such as European Respiratory Journal, Emerging infectious diseases and American Journal of Physiology-Lung Cellular and Molecular Physiology.

In The Last Decade

H. Blau

17 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Blau Israel	10	306	231	140	117	96	19	591
Daniel Dorgan United States	9	163 0.5×	172 0.7×	162 1.2×	75 0.6×	89 0.9×	21	438
Sina Marsilio United States	12	196 0.6×	41 0.2×	103 0.7×	94 0.8×	183 1.9×	28	397
Matthew M. Hewitt United States	7	115 0.4×	180 0.8×	225 1.6×	40 0.3×	91 0.9×	8	507
Clare Knottenbelt United Kingdom	15	152 0.5×	51 0.2×	43 0.3×	188 1.6×	61 0.6×	38	564
J.L. Yntema Netherlands	10	146 0.5×	109 0.5×	108 0.8×	21 0.2×	43 0.4×	20	385
Wilfried H. Nikolaizik Germany	11	273 0.9×	83 0.4×	120 0.9×	17 0.1×	122 1.3×	18	695
Nora Berghoff United States	13	276 0.9×	30 0.1×	54 0.4×	197 1.7×	99 1.0×	24	496
M Goodfellow United Kingdom	9	164 0.5×	83 0.4×	18 0.1×	98 0.8×	54 0.6×	17	412
Karin Muth Beale United States	14	68 0.2×	77 0.3×	37 0.3×	106 0.9×	11 0.1×	23	370
Jessica Powell Australia	13	205 0.7×	78 0.3×	130 0.9×	9 0.1×	152 1.6×	16	606

Countries citing papers authored by H. Blau

Since Specialization

Citations

This map shows the geographic impact of H. Blau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Blau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Blau more than expected).

Fields of papers citing papers by H. Blau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Blau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Blau. The network helps show where H. Blau may publish in the future.

Co-authorship network of co-authors of H. Blau

This figure shows the co-authorship network connecting the top 25 collaborators of H. Blau. A scholar is included among the top collaborators of H. Blau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Blau. H. Blau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Kerem, Eitan, H. Blau, Michal Shteinberg, et al.. (2017). WS01.2 Phase II clinical trial results of alidornase alfa for the treatment of cystic fibrosis. Journal of Cystic Fibrosis. 16. S1–S1. 4 indexed citations

Shteinberg, Michal, Zeev Blumenfeld, Michal Gur, et al.. (2016). 223 Infertility among women with cystic fibrosis: prevalence and risk factors. Journal of Cystic Fibrosis. 15. S108–S108.

Wilschanski, Michael, L.L. Miller, David Shoseyov, et al.. (2011). Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis. European Respiratory Journal. 38(1). 59–69. 151 indexed citations

Grisaru‐Soen, Galia, Liat Lerner‐Geva, Eitan Kerem, et al.. (2008). Multicenter Cross-Sectional Study of Nontuberculous Mycobacterial Infections among Cystic Fibrosis Patients, Israel. Emerging infectious diseases. 14(3). 378–384. 155 indexed citations

Wilschanski, M., S. Armoni, Yasmin Yaakov, et al.. (2008). PTC124 treatment over 3 months improves pharmacodynamic and clinical parameters in patients with nonsense-mutation-mediated CF. Journal of Cystic Fibrosis. 7. S22–S22. 10 indexed citations

Kerem, Eitan, Samit Hirawat, S. Armoni, et al.. (2007). 41* PTC124 activity in CF patients carrying stop mutations: results of a phase 2 study. Journal of Cystic Fibrosis. 6. S10–S10. 2 indexed citations

Mussaffi, Huda, Dario Prais, Meir Mei‐Zahav, & H. Blau. (2006). Cystic Fibrosis Mutations with Widely Variable Phenotype: The D1152H Example. Pediatric Pulmonology. 41(3). 250–254. 25 indexed citations

Mussaffi, Huda, Joseph Rivlin, Itamar Shalit, Moshe Ephros, & H. Blau. (2005). Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. European Respiratory Journal. 25(2). 324–328. 87 indexed citations

Augarten, Arie, Gideon Paret, Micha Aviram, et al.. (2004). Systemic inflammatory mediators and cystic fibrosis genotype. Clinical and Experimental Medicine. 4(2). 99–102. 21 indexed citations

10.

Augarten, Arie, Micha Aviram, H. Blau, et al.. (2003). Serum CA 19?9 levels as a diagnostic marker in cystic fibrosis patients with borderline sweat tests. Clinical and Experimental Medicine. 3(2). 119–123. 6 indexed citations

11.

Mussaffi, Huda, et al.. (2000). Reaching the diagnosis of cystic fibrosis--the limits of the spectrum.. PubMed. 2(2). 94–8. 10 indexed citations

12.

Augarten, Arie, Eitan Kerem, B. Kerem, et al.. (1995). The significance of sweat Cl/Na ratio in patients with borderline sweat test. Pediatric Pulmonology. 20(6). 369–371. 30 indexed citations

13.

Kalina, M., et al.. (1995). Interaction of surfactant protein A with bacterial lipopolysaccharide may affect some biological functions. American Journal of Physiology-Lung Cellular and Molecular Physiology. 268(1). L144–L151. 45 indexed citations

14.

Bujanover, Yoram, et al.. (1988). The development of the chymotryptic activity during postnatal life using the Bentiromide test. International Journal of Pancreatology. 3(1). 53–58. 6 indexed citations

15.

Blau, H., et al.. (1983). Studies on Human Milk Macrophages: Effect of Activation on Phagocytosis and Secretion of Prostaglandin E2 and Lysozyme. Pediatric Research. 17(4). 241–245. 30 indexed citations

16.

Blau, H., et al.. (1983). Thyroid function in cystic fibrosis patients compared with healthy Israeli children.. PubMed. 19(1). 17–9. 3 indexed citations

17.

Shalev, J., et al.. (1982). The prenatal ultrasonic diagnosis of Urethral obstruction and diverticulum of the urinary bladder. Pediatric Radiology. 12(1). 48–50. 4 indexed citations

18.

Blau, H., et al.. (1966). Das postprandiale Verhalten von Blutbasophilen und veresterten Serumfettsäuren im Kindesalter. Journal of Molecular Medicine. 44(14). 847–848. 1 indexed citations

19.

Blau, H. & W Plenert. (1965). Basophile und eosinophile Granulocyten bei gesunden und kranken Kindern. European Journal of Pediatrics. 94(3). 280–288. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact